IGC - India Globalization Capital, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD

India Globalization Capital, Inc.

4336 Montgomery Avenue
Bethesda, MD 20814
United States

IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees16

Key Executives

NameTitlePayExercisedYear Born
Mr. Ram MukundaExec. Chairman, Pres & CEO300kN/A1959
Ms. Claudia GrimaldiVP & Principal Financial OfficerN/AN/A1971
Mr. Rohit GoelPrincipal Accounting OfficerN/AN/A1994
Dr. Jagadeesh RaoScientific OfficerN/AN/A1967
Mr. Shajy MathilakathuCo-Principal Financial & Accounting OfficerN/AN/A1968
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


India Globalization Capital, Inc. engages in the development of cannabis-based therapies to treat Alzheimer's, pain, nausea, eating disorders, several end points of Parkinson's, and epilepsy in humans, dogs, and cats. The company's products under medical trials include Natrinol, a natural substitute for Marinol for relieving nausea, vomiting, and increasing appetite in patients with AIDS and cancer; Caesafin to alleviate seizures in dogs and cats; Serosapse addresses several end points in Parkinson's disease, including Rapid Eye Movement sleep disorder, anxiety, and dyskinesia; and Hyalolex to reduce the buildup of beta-amyloid in Alzheimer's patients. It also provides construction management services for the construction of a 7-star hotel in Genting Malaysia; and rents heavy equipment with operators to construction companies. India Globalization Capital, Inc. has a joint development and services agreement with The Parkinson's Institute and Clinical Center to develop cannabis related products for treating various end points of Parkinson's disease and movement disorders. The company was founded in 2005 and is based in Bethesda, Maryland.

Corporate Governance

India Globalization Capital, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.